(Total Views: 173)
Posted On: 06/27/2019 4:35:46 PM
Post# of 89338

$ZIOP News Article - Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled IL-12 with Libtayo (cemiplimab-rwlc) to Treat Patients with Recurrent Glioblastoma https://marketwirenews.com/news-releases/ziop...27130.html


My Twitter: WhyteStocks